Document Detail


Recovery of orbital fat pad prolapsus and deepening of the lid sulcus from topical bimatoprost therapy: 2 case reports and review of the literature.
MedLine Citation:
PMID:  20670089     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
OBJECTIVES: To report 2 cases of resolution of orbital fat pad prolapsus and deepening of the lid sulcus caused by topical bimatoprost therapy, and to review the literature.
METHODS: This was a retrospective, observational chart review.
RESULTS: A 54-year-old man with normotensive glaucoma presented with recovery of left lower lid orbital fat pad prolapsus, deepening of the lid sulcus, and iris color and eyelash changes 8 months after initiation of bimatoprost therapy in his left eye (OS). After stopping bimatoprost, his eyelashes and the lower lid orbital fat pad partially regained their natural appearance at 2 months and 4 months, respectively. However, there was no improvement of the left upper eyelid deepening and the iris hyperpigmentation, even after 30 months. A 75-year-old man with unilateral pseudoexfoliative glaucoma had been treated with bimatoprost OS. Three months after initiation of the therapy, his examination showed recovery of the inferior and superomedial orbital fat pad prolapsus, a deep and prominent upper lid sulcus with eyelash changes, and iris hyperpigmentation OS. Five months after discontinuation of bimatoprost, the eyelashes and superomedial orbital fat pad improved. Twenty-four months later, the inferior orbital fat pad partially got its natural appearance back, but the upper lid sulcus was slightly more deep and prominent than the fellow right eye. There was no alteration in iris hyperpigmentation.
CONCLUSION: Clinicians and patients should be aware of these possible effects of topical bimatoprost therapy. These adverse effects may not be completely reversible after discontinuation of the medication.
Authors:
Sayime Aydin; Işil Işikligil; Yasemin Aktan Tekşen; Erkin Kir
Related Documents :
8640439 - Cluster headache presenting with orbital inflammation.
16329069 - Unilateral exophthalmos associated with ipsilateral mucosal turbinate hypertrophy: beni...
3324649 - Intrasphenoidal encephaloceles--a clinical entity.
7885559 - Primary intraosseous orbital hemangioma: a case report and review of the literature.
2114459 - Maxillary antrum hypoplasia. report of a case.
19839909 - Ectopic orbital brain diagnosed 20 years after symptomatic presentation.
1413309 - Urethral tuberculosis.
24372009 - Punctate pemphigus: an underreported direct immunofluorescence pattern.
23601229 - Oral mucositis in patients receiving low-dose methotrexate therapy for rheumatoid arthr...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Cutaneous and ocular toxicology     Volume:  29     ISSN:  1556-9535     ISO Abbreviation:  Cutan Ocul Toxicol     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-07-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101266892     Medline TA:  Cutan Ocul Toxicol     Country:  England    
Other Details:
Languages:  eng     Pagination:  212-6     Citation Subset:  IM    
Affiliation:
Ophthalmology Department, Dumlupinar University School of Medicine, Kutahya, Turkey. sayimeaydin@gmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hyposensitization in the treatment of resistant cases of vernal keratoconjunctivitis.
Next Document:  Toxic anterior segment syndrome presenting as isolated cystoid macular edema after removal of entrap...